Status:
COMPLETED
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
Lead Sponsor:
Innovative Medical
Conditions:
Vitrectomy
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
To compare the penetration of three different NSAIDs.
Eligibility Criteria
Inclusion
- Males or females scheduled to undergo Vitrectomy surgery
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00377546
Last Update
September 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States, 02114